Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2010
06/23/2010EP2197280A2 Pyrazole compounds for controlling invertebrate pests
06/23/2010EP1646629B1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1926133B Epothilone derivatives
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN1821236B Therapeutic heterocyclic compounds
06/23/2010CN101755012A azo dyes
06/23/2010CN101754969A Processes for making epothilone compounds and analogs
06/23/2010CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors
06/23/2010CN101754965A CSF-1R inhibitors, compositions, and methods of use
06/23/2010CN101754962A N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 for the treatment of diabetes and metabolic disorders
06/23/2010CN101747331A Isoniazid thiadiazine thione derivative
06/23/2010CN101747330A Pyridyl thiazole amines compound, as well as medical composite and application thereof
06/23/2010CN101747329A 4-arylthioquinazoline derivatives and preparation methods and pharmaceutical uses thereof
06/23/2010CN101747328A Synthesis method of single-ring imipenem p-nitro benzyl ester
06/23/2010CN101747327A Aromatic amide thiazole derivative, preparation method and application thereof
06/23/2010CN101747326A 18- or 14-macrolide epothilone compound and application thereof
06/23/2010CN101747325A Neighboring Heterocyclic formanilide compound and synthesis method and application thereof
06/23/2010CN101747320A Dialdehyde-built disinsection activity-having nitrogen or oxygen-containing heterocyclic compound and preparation method
06/23/2010CN101747253A Trisubstituted chiral lactam derivative and preparation method and application thereof
06/23/2010CN101104617B Dihydropyrimidine compounds and use of the same in preparing medicament for curing and preventing virosis
06/22/2010US7741480 Process for the preparation of linezolid and related compounds
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/22/2010CA2412718C Viral polymerase inhibitors
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/17/2010WO2010068761A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010067374A2 Polymorphs of dasatinib
06/17/2010WO2010067136A1 Novel crystalline forms
06/17/2010WO2010067125A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010WO2010067123A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010WO2010067067A1 Compounds for treating cancer
06/17/2010WO2010066697A1 Fungicide hydroximoyl-heterocycles derivatives
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010066357A1 Benzothiazole amides for detection of amyloid beta
06/17/2010WO2010066353A1 Thiazolyl oxime ether and hydrazones asl plant protection agent
06/17/2010WO2010033444A8 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
06/17/2010WO2010013141A3 Substantially pure rosiglitazone hydrogen sulfate
06/17/2010US20100152440 NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152203 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152191 Cyclopropyl pyrrolidine orexin receptor antagonists
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100151064 Thiazolhydrazides for treatment of neurodegenerative diseases
06/17/2010CA2747185A1 Compounds for treating cancer
06/17/2010CA2746433A1 Benzothiazole amides for detection of amyloid beta
06/17/2010CA2746265A1 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010CA2745725A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010CA2745063A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/16/2010EP2196454A2 Exo-and diastereo-selective syntheses of himbacine analogs
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2195312A1 Pyridine derivatives useful as glucokinase activators
06/16/2010EP2195311A1 Pyridine derivatives as s1p1/edg1 receptor modulators
06/16/2010EP2195289A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists
06/16/2010EP2194986A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010EP1651958B1 Novel chemiluminescent compounds and their use
06/16/2010CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase
06/16/2010CN1867566B Aminopyrones and their use as ATM inhibitors
06/16/2010CN1803798B Method for producing fungicide compand
06/16/2010CN1774428B M-stage kinesin inhibitor
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN101743242A Heterocyclic compounds useful as RAF kinase inhibitors
06/16/2010CN101743241A pyridazinone derivates
06/16/2010CN101743239A cyanoisoquinoline
06/16/2010CN101743237A condensed anthranilamide insecticides
06/16/2010CN101743234A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
06/16/2010CN101743229A quinazolinamide derivatives
06/16/2010CN101743224A 7-substituted indole mcl-1 inhibitors
06/16/2010CN101735212A Controlled synthesis of ziprasidone and compositions thereof
06/16/2010CN101735211A Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor
06/16/2010CN101735200A Quinazoline compound
06/16/2010CN101048403B Heterocyclic antiviral compounds
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737172 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections
06/15/2010US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds
06/15/2010US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/15/2010CA2529686C 2-acylaminothiazole derivative or salt thereof
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 628